[Erythropoietin in the prevention and treatment of anemia in heart surgery patients].
The authors present results of using recombinant human erythropoietin in patients operated on the heart under conditions of extracorporeal blood circulation. It was found that the intravenous infusions of erythropoietin at the postoperative period accelerated the restitution of circulating erythron indices. The volume of transfusion of the donor erythrocyte-containing media to the patient is given erythropoietin was reliably less than that in the control group. The results obtained allow using erythropoietin to be recommended as an effective method of prophylactics and treatment of anemia in cardiosurgical patients.
Shevchenko
Iu L
IuL
Khubulava
G G
GG
Chechetkin
A V
AV
Belevitin
A B
AB
Solov'eva
N Iu
NIu
D000328:Adult; D000740:Anemia / Q000097:blood / Q000188:drug therapy / Q000517:prevention & control*; D006348:Cardiac Surgical Procedures; D004697:Endocarditis, Bacterial / Q000097:blood / Q000601:surgery; D004921:Erythropoietin / Q000627:therapeutic use*; D005112:Extracorporeal Circulation; D005260:Female; D006330:Heart Defects, Congenital / Q000097:blood / Q000601:surgery; D006801:Humans; D007036:Hypothermia, Induced; D008297:Male; D011182:Postoperative Care; D011183:Postoperative Complications / Q000097:blood / Q000188:drug therapy / Q000517:prevention & control*; D011994:Recombinant Proteins; D012214:Rheumatic Heart Disease / Q000097:blood / Q000601:surgery
D011994:Recombinant Proteins; D004921:Erythropoietin